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possible to cause nucleic acid
molecules to evolve in the test tube.
With the discovery of catalytic RNA,
and advances in nucleic acid
amplification techniques such as the
polymerase chain reaction, it became
possible to construct laboratory
systems that allow the Darwinian
evolution of functional RNA (and
later DNA) molecules. This is not
evolution based on natural selection,
but rather directed evolution based on
selection constraints imposed by the
experimenter. We’ve been playing
these in vitro evolution games in my
own laboratory for the past 10 years.
The counterforce, it turns out, is
not much to look at — typically,
20 microliters of a clear, colorless
solution. But in those solutions the
Titans are rumbling. We can begin in
the lab on a Monday with a
population of 1014 random-sequence
nucleic acid molecules and by Friday
witness the emergence of order in
the form of macromolecules of a
particular sequence that perform a
specific catalytic task. Over the
week, the evolving system has
expended more than 1017 energy-rich
nucleoside triphosphates, but has
created an island of order in a
universe that is forever tumbling
toward a state of maximum entropy.
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Quick guide
Hydrogen bonding
Peter A. Kollman
What is it? A hydrogen bond is an
interaction in which a hydrogen atom
bridges two electronegative atoms (in
biological systems, usually nitrogen
or oxygen).
Why is it important in biological systems?
Hydrogen bonds hold the two
strands of a DNA helix together, and
in proteins they hold α-helices and
β-sheets together. They are perfect
for the job — weaker than covalent
bonds but strong enough to provide
specificity and directionality in, say,
DNA replication.
Where would we be without it? Unstuck.
So, what defines a hydrogen bond?
Classically, a hydrogen bond is said
to exist in an A–H…B system (where
A and B are the ‘end atoms’ of the
bond), when the distance between H
and B is significantly less than the
sum of the van der Waals radii of H
and B. Also, the angle A–H…B
should be near 180°. Typically, any
distance between H and B of less
than 3.5 Å, with a deviation of the
angle from linearity of less than 30°
is considered to be a hydrogen bond.
Well, you did ask.
How does it work? Put simply, a
hydrogen bond involves an attraction
of an electron donor atom (Bδ–) for a
proton donor group (Aδ––Hδ+). As the
hydrogen bond gets stronger, there is
more electron delocalization and
covalent character in the hydrogen
bond, until the hydrogen is fully
shared between the end atoms, A and
B. In strong, short hydrogen bonds,
the hydrogen atom is located midway
between the end atoms and the
distance between these end atoms is
2.3–2.7 Å. Such bonds are often called
‘low-barrier’ hydrogen bonds.
How do I know if it’s a hydrogen bond?
Neutron diffraction crystallography is
the most definitive way to detect a
hydrogen bond but low-temperature
x-ray crystallography can also be used.
Hydrogen atoms involved in
hydrogen bonding are shifted
downfield in NMR data and
red-shifted in vibrational spectroscopy
data, so these are the best ways to
determine whether a molecule is
hydrogen bonded in solution.
How strong is it? Hydrogen bond
strengths can vary from 5 kJ/mole to
hundreds of kJ/mole, depending on
the molecules and whether they are
in a gas or a solution. For example, a
guanine–cytosine hydrogen bond
has a strength of about
80–100 kJ/mole in the gas phase and
less than 20 kJ/mole in aqueous
solution.
How much is a hydrogen bond worth in
a protein? The answer to this
question is much debated and, so far,
unresolved. Site-specific mutations
that convert hydrogen-bonding
amino acids to amino acids that don’t
hydrogen bond often have little
effect on the free energy of protein
stability or binding; however, this
could be because any effects are
counterbalanced by changes in the
residue’s hydrogen bonding with the
aqueous solvent.
Why is there so much fuss about
low-barrier hydrogen bonds? Many
people think that low-barrier
hydrogen bonds are important in
enzyme catalysis, but these
arguments are often based on
hydrogen bond strengths in the gas
phase, which can be misleading.
No one disputes the existence of
low-barrier hydrogen bonds, which
can be detected using NMR, but it’s
not clear whether they have any real
energetic consequences for catalysis.
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Magazine R501
The editors of Current Biology have
invited a number of biologists to reveal
the work that has influenced them most
profoundly in their careers. These brief
essays are published in the Turning
points series. If you have any comments,
or ideas arising from this series, we shall
be happy to consider them.
